4.7 Article

Temozolomide protects against the progression of glioblastoma via SOX4 downregulation by inhibiting the LINC00470-mediated transcription factor EGR2

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

miR-490 suppresses telomere maintenance program and associated hallmarks in glioblastoma

Omkar Suhas Vinchure et al.

Summary: miR-490 targets multiple genes to regulate telomere maintenance in GBM, exerting tumor suppressive effects, impacting stemness and senescence, activating DNA damage response, and potentially holding therapeutic significance in GBM treatment.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Review Biochemistry & Molecular Biology

Molecular Mechanisms of Treatment Resistance in Glioblastoma

Alexander Ou et al.

Summary: Glioblastoma is the most common malignant primary brain tumor in adults and is almost invariably fatal. The challenges of treating glioblastoma include the blood-brain barrier, tumoral heterogeneity, and immunosuppressive microenvironment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell Biology

Early growth response 2 (EGR2) is a novel regulator of the senescence programme

Eleanor J. Tyler et al.

Summary: EGR2 is identified as a novel regulator of senescence, with up-regulated expression during senescence. It activates the ARF and p16 promoters and directly binds to them. Loss of EGR2 results in down-regulation of p16 levels and an increase in the population of p16- p21- 'reversed' cells.

AGING CELL (2021)

Article Cell Biology

Nicardipine sensitizes temozolomide by inhibiting autophagy and promoting cell apoptosis in glioma stem cells

Jia Shi et al.

Summary: The study found that nicardipine can enhance the toxic effect of temozolomide against GSCs, promote apoptosis of GSCs, and inhibit autophagy. These effects are related to the activation of mTOR, and the selective inhibition of mTOR by rapamycin can weaken the sensitization of nicardipine to temozolomide.

AGING-US (2021)

Article Oncology

Long non-coding RNA LINC00470 in serum derived exosome: a critical regulator for proliferation and autophagy in glioma cells

Wenjia Ma et al.

Summary: The study revealed that LINC00470 is overexpressed in serum exosomes from glioma patients and is associated with disease severity and postoperative survival time. Exosomes can worsen tumor progression in nude mice and activate the PI3K/AKT/mTOR pathway by regulating the expression of miR-580-3p and WEE1, inhibiting autophagy and enhancing the proliferation of glioma cells.

CANCER CELL INTERNATIONAL (2021)

Article Biochemistry & Molecular Biology

Silencing of ZFP36L2 increases sensitivity to temozolomide through G2/M cell cycle arrest and BAX mediated apoptosis in GBM cells

Mohd Firdaus Che Mat et al.

Summary: By employing RNA interference to target the ZFP36L2 gene, increased chemosensitivity to temozolomide was observed in LN18 GBM cells, leading to enhanced apoptosis, cell cycle arrest, and decreased proliferation. This suggests a potential therapeutic intervention for GBM in the future involving RNAi combined with chemotherapy like temozolomide.

MOLECULAR BIOLOGY REPORTS (2021)

Article Cell Biology

Dysregulation of LINC00470 and METTL3 promotes chemoresistance and suppresses autophagy of chronic myelocytic leukaemia cells

Xun Lai et al.

Summary: This study unraveled the molecular mechanism by which LINC00470 reduces PTEN stability via RNA methyltransferase METTL3, leading to the inhibition of cell autophagy and promotion of chemoresistance in CML.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Cell Biology

LINC00470 accelerates the proliferation and metastasis of melanoma through promoting APEX1 expression

Ting Huang et al.

Summary: Studies have shown that LINC00470 enhances the expression of APEX1 in melanoma by activating the transcription factor ZNF131, thereby promoting the proliferation and migration of melanoma cells. This suggests that LINC00470 may be a potential therapeutic target for the treatment of melanoma.

CELL DEATH & DISEASE (2021)

Article Cell Biology

EGR2-mediated regulation of m6A reader IGF2BP proteins drive RCC tumorigenesis and metastasis via enhancing S1PR3 mRNA stabilization

Yufan Ying et al.

Summary: In renal cell cancer, IGF2BPs regulate the expression of S1PR3 in an m(6)A-dependent manner and promote kidney tumorigenesis by enhancing the stability of S1PR3 mRNA. Upregulation of IGF2BPs and WTAP in RCC predicts poor overall survival.

CELL DEATH & DISEASE (2021)

Review Medicine, Research & Experimental

LncRNAs associated with glioblastoma: From transcriptional noise to novel regulators with a promising role in therapeutics

Bhupender Yadav et al.

Summary: This review discusses the specific involvement of long non-coding RNAs in the pathogenesis of glioblastoma multiforme, focusing on their association with key molecular and cellular regulatory mechanisms. Novel RNA-based strategies for therapeutic purposes are also highlighted.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Review Chemistry, Multidisciplinary

Electrotherapies for Glioblastoma

Elise P. W. Jenkins et al.

Summary: This review discusses the unique therapeutic strategy of non-thermal, intermediate frequency electrotherapies in treating malignant neoplasms, with a focus on glioblastoma (GBM). The biological aspects of GBM and electrophysiological traits that contribute to treatment complexity are described, along with attempts to bridge the gap between electrotherapy techniques and targeting the biological complexities of GBM. The review aims to offer future research directions in understanding and treating GBM, by assessing the biological effects of different aspects of intermediate frequency electrotherapy methods.

ADVANCED SCIENCE (2021)

Review Cell Biology

The Interplay between Glioblastoma and Its Microenvironment

Mark Dapash et al.

Summary: GBM, the most common primary brain tumor in adults, has poor prognosis due to its aggressive nature; treatments, including immunotherapies, are hindered by the complex interactions within the tumor microenvironment; understanding and manipulating the different components and pressures in the TME can lead to more targeted therapies and potentially improved patient outcomes.

CELLS (2021)

Article Oncology

LINC00470 Stimulates Methylation of PTEN to Facilitate the Progression of Endometrial Cancer by Recruiting DNMT3a Through MYC

Tiezhong Yi et al.

Summary: Researches have found that LINC00470 is upregulated in endometrial cancer and correlates with patient prognosis. LINC00470 promotes the invasiveness, migration, and angiogenesis of endometrial cancer cells, and facilitates tumor formation and metastasis in vivo, effects that can be reversed by upregulating PTEN. Furthermore, LINC00470 stimulates PTEN methylation through MYC-induced recruitment of DNMT3a, exacerbating the progression of endometrial cancer.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Interplay of m6A and histone modifications contributes to temozolomide resistance in glioblastoma

Fuxi Li et al.

Summary: Our study identified that TMZ treatment upregulated the m(6)A methyltransferase METTL3, enhancing m(6)A modification of histone modification-related gene transcripts. METTL3 is crucial for maintaining GBM stem cell features, and its silencing in combination with TMZ inhibited orthotopic TMZ-resistant xenograft growth.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Review Oncology

SOX4: The unappreciated oncogene

Carlos S. Moreno

SEMINARS IN CANCER BIOLOGY (2020)

Article Biochemistry & Molecular Biology

LncRNA LINC00470 promotes the degradation of PTEN mRNA to facilitate malignant behavior in gastric cancer cells

Jijun Yan et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Review Oncology

Brain malignancies: Glioblastoma and brain metastases

Tamara T. Lah et al.

SEMINARS IN CANCER BIOLOGY (2020)

Article Biochemistry & Molecular Biology

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma

Chenfei Lu et al.

MOLECULAR CANCER (2020)

Article Oncology

SOX4 promotes the growth and metastasis of breast cancer

Jing Zhang et al.

CANCER CELL INTERNATIONAL (2020)

Review Oncology

Glioblastoma vs temozolomide: can the red queen race be won?

Anjali Arora et al.

CANCER BIOLOGY & THERAPY (2019)

Article Oncology

Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells

Raghupathy Vengoji et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Review Oncology

Molecular targeted therapy of glioblastoma

Emilie Le Rhun et al.

CANCER TREATMENT REVIEWS (2019)

Article Biotechnology & Applied Microbiology

LINC00470 Coordinates the Epigenetic Regulation of ELFN2 to Distract GBM Cell Autophagy

Changhong Liu et al.

MOLECULAR THERAPY (2018)

Review Clinical Neurology

Multidimensional communication in the microenvirons of glioblastoma

Marike L. Broekman et al.

NATURE REVIEWS NEUROLOGY (2018)

Review Clinical Neurology

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma

Shabierjiang Jiapaer et al.

NEUROLOGIA MEDICO-CHIRURGICA (2018)

Article Multidisciplinary Sciences

Differential Expression of ID4 and Its Association with TP53 Mutation, SOX2, SOX4 and OCT-4 Expression Levels

Thais Fernanda de Almeida Galatro et al.

PLOS ONE (2013)